E. Woods

649 total citations
12 papers, 507 citations indexed

About

E. Woods is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, E. Woods has authored 12 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in E. Woods's work include Breast Cancer Treatment Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). E. Woods is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). E. Woods collaborates with scholars based in United Kingdom, United States and Italy. E. Woods's co-authors include R. Charles Coombes, Judith M. Bliss, J. Wils, M. Marty, P. Vassilopoulos, F. Morvan, Faustino R. Pérez‐López, Gill Coombes, R. W. Moskowitz and A. Kivitz and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and British Journal of Cancer.

In The Last Decade

E. Woods

12 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Woods United Kingdom 9 247 174 123 120 98 12 507
Min Hoe Chew Singapore 13 242 1.0× 108 0.6× 123 1.0× 21 0.2× 174 1.8× 47 477
Vikas Khurana United States 11 107 0.4× 307 1.8× 227 1.8× 30 0.3× 267 2.7× 37 573
S. S. Ngoi Singapore 16 173 0.7× 43 0.2× 318 2.6× 43 0.4× 632 6.4× 32 911
J. Shapira Israel 14 232 0.9× 48 0.3× 149 1.2× 19 0.2× 114 1.2× 41 672
Andrea Rajnakova Singapore 11 191 0.8× 87 0.5× 395 3.2× 47 0.4× 540 5.5× 21 908
Tatsuya Tsuji Japan 15 414 1.7× 56 0.3× 230 1.9× 39 0.3× 398 4.1× 50 753
Giorgio Zanette Italy 12 126 0.5× 112 0.6× 68 0.6× 16 0.1× 307 3.1× 21 812
Kristin Kaley United States 12 323 1.3× 85 0.5× 101 0.8× 27 0.2× 77 0.8× 36 447
Thomas Cerny Switzerland 16 508 2.1× 91 0.5× 443 3.6× 16 0.1× 182 1.9× 28 966
Annette B. Beiderbeck United Kingdom 9 144 0.6× 401 2.3× 258 2.1× 46 0.4× 299 3.1× 14 658

Countries citing papers authored by E. Woods

Since Specialization
Citations

This map shows the geographic impact of E. Woods's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Woods with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Woods more than expected).

Fields of papers citing papers by E. Woods

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Woods. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Woods. The network helps show where E. Woods may publish in the future.

Co-authorship network of co-authors of E. Woods

This figure shows the co-authorship network connecting the top 25 collaborators of E. Woods. A scholar is included among the top collaborators of E. Woods based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Woods. E. Woods is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chacko, Shaji, Hülya Taşkapan, Julia Roscoe, et al.. (2009). Treatment of hyper-IgG4 disease with sequential corticosteroids and tamoxifen – case report and review of the literature. Clinical Nephrology. 72(11). 414–413. 8 indexed citations
3.
Nitti, Donato, J. Wils, George Fountzilas, et al.. (2005). Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Annals of Oncology. 17(2). 262–269. 67 indexed citations
4.
Kivitz, A., et al.. (2001). Comparative Efficacy and Safety of Celecoxib and Naproxen in the Treatment of Osteoarthritis of the Hip. Journal of International Medical Research. 29(6). 467–479. 83 indexed citations
5.
Wils, J., Judith M. Bliss, M. Marty, et al.. (1999). Epirubicin Plus Tamoxifen Versus Tamoxifen Alone in Node-Positive Postmenopausal Patients With Breast Cancer: A Randomized Trial of the International Collaborative Cancer Group. Journal of Clinical Oncology. 17(7). 1988–1988. 63 indexed citations
6.
Cortazar, Patricia, Adi F. Gazdar, E. Woods, et al.. (1997). Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.. PubMed. 3(5). 741–7. 31 indexed citations
9.
Roth, S H, et al.. (1993). Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis.. Annals of the Rheumatic Diseases. 52(12). 881–885. 45 indexed citations
10.
Topham, C., J. Glees, Nigel S. B. Rawson, E. Woods, & R. Charles Coombes. (1991). Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas. British Journal of Cancer. 64(1). 179–181. 22 indexed citations
11.
Roth, S., N M Agrawal, Maren L. Mahowald, et al.. (1987). Misoprostol heals aspirin induced gastropathy in rheumatoid arthritis. 59. 4 indexed citations
12.
Benjamin, S, et al.. (1983). The Angelchik Antireflux Prosthesis Effects on the Lower Esophageal Sphincter of Primates. Annals of Surgery. 197(1). 63–67. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026